UL Solutions (ULS) Equity Ratio (2023 - 2026)
Quarterly results put Equity Ratio at 0.45 for Q1 2026, up 32.23% from a year ago — trailing twelve months through Mar 2026 was 0.45 (up 32.23% YoY), and the annual figure for FY2025 was 0.43, up 29.94%.
UL Solutions has reported Equity Ratio over the past 4 years, most recently at 0.45 for Q1 2026.
- Equity Ratio reached 0.45 in Q1 2026 per ULS's latest filing, up from 0.43 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.45 in Q1 2026 and bottomed at 0.24 in Q1 2024.
- Median Equity Ratio over the past 4 years was 0.34 (2024), compared with a mean of 0.34.
- Peak annual rise in Equity Ratio hit 41.12% in 2025, while the deepest fall reached 29.94% in 2025.
- Over 4 years, Equity Ratio stood at 0.25 in 2023, then soared by 34.18% to 0.33 in 2024, then grew by 29.94% to 0.43 in 2025, then grew by 4.65% to 0.45 in 2026.
- Business Quant data shows Equity Ratio for ULS at 0.45 in Q1 2026, 0.43 in Q4 2025, and 0.41 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | 0.16 |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | 70.46 |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 0.47 |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 0.92 |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 0.45 |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | 0.37 |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 0.45 |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 0.24 |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 0.42 |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | 0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.45 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.33 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.24 |
| Dec 31, 2023 | 0.25 |